The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively by Cornaciu, Irina et al.
The Minimal Domain of Adipose Triglyceride Lipase
(ATGL) Ranges until Leucine 254 and Can Be Activated
and Inhibited by CGI-58 and G0S2, Respectively
Irina Cornaciu, Andras Boeszoermenyi, Hanna Lindermuth, Harald M. Nagy, Ines K. Cerk, Catharina
Ebner, Barbara Salzburger, Astrid Gruber, Martina Schweiger, Rudolf Zechner, Achim Lass, Robert
Zimmermann, Monika Oberer*
Institute of Molecular Biosciences, University of Graz, Graz, Austria
Abstract
Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme of lipolysis. ATGL specifically hydrolyzes triacylglycerols (TGs),
thereby generating diacylglycerols and free fatty acids. ATGL’s enzymatic activity is co-activated by the protein comparative
gene identification-58 (CGI-58) and inhibited by the protein G0/G1 switch gene 2 (G0S2). The enzyme is predicted to act
through a catalytic dyad (Ser47, Asp166) located within the conserved patatin domain (Ile10-Leu178). Yet, neither an
experimentally determined 3D structure nor a model of ATGL is currently available, which would help to understand how
CGI-58 and G0S2 modulate ATGL’s activity. In this study we determined the minimal active domain of ATGL. This minimal
fragment of ATGL could still be activated and inhibited by CGI-58 and G0S2, respectively. Furthermore, we show that this
minimal domain is sufficient for protein-protein interaction of ATGL with its regulatory proteins. Based on these data, we
generated a 3D homology model for the minimal domain. It strengthens our experimental finding that amino acids
between Leu178 and Leu254 are essential for the formation of a stable protein domain related to the patatin fold. Our data
provide insights into the structure-function relationship of ATGL and indicate higher structural similarities in the N-terminal
halves of mammalian patatin-like phospholipase domain containing proteins, (PNPLA1, -2,- 3 and -5) than originally
anticipated.
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Introduction
In most organisms, excess energy is stored in form of
triacylglycerol (TG) in lipid droplets (LDs). During periods of
increased energy demand, TG undergoes a hydrolytic process
termed lipolysis which results in the release of free fatty acids (FAs)
and glycerol as energy substrates. Lipolysis is carried out as a
hydrolytic cascade of consecutive reactions catalyzed by different
lipases [1,2,3,4]. Adipose triglyceride lipase (ATGL) was shown to
be the rate-limiting enzyme in this process [1]. It catalyzes the
hydrolysis of TG into diacylglycerol (DG) and FA during basal and
hormone stimulated lipolysis [1,5,6,7,8]. The enzyme was
discovered independently by three different laboratories and is
also known as PNPLA2 (patatin-like phospholipase domain
containing-2), desnutrin, phospholipase A2f and transport secre-
tion protein 2.2 [1,5,6]. Patients with mutations in the gene coding
for ATGL develop neutral lipid storage disease with myopathy
(NLSDM) which is characterized by systemic TG accumulation in
multiple tissues and cardiomyopathy [4,9,10].
Mouse and human ATGL genes encode proteins with 486 and
504 amino acids, respectively and share 84% sequence identity.
No 3D structure for ATGL is available; however sequence analysis
revealed that ATGL harbors a patatin domain located between
amino acids Ile10-Leu178 (Figure 1) [11]. In mammals, an entire
protein family was classified as patatin-like phospholipase domain
containing family (PNPLA) [12]. PNPLAs are characterized to
different extents and are mostly lipid hydrolases with varying
substrate specificities (e.g. TG, retinol ester, or phospholipid).
Throughout all organisms, only two proteins with known 3D
structures harbor the patatin domain: the name giving plant
protein patatin, Pat17, and the catalytic domain of human
cytosolic phospholipase A2 (cPLA2) [13,14]. Based on similar
features of ATGL with these proteins, it can be assumed that
ATGL acts through a catalytic dyad similar to cPLA2 and Pat17
(Figure 1). The essential role of the putative dyad residues Ser47
and Asp166 in ATGL was experimentally confirmed by mutation
studies [15,16,17]. In vivo, ATGL is reported to be localized in the
cytoplasm, on LDs and in membranes [1,18,19]. LD localization is
attributed to a hydrophobic stretch which is in the C-terminal half
of ATGL, Val315 to Ile364 (Figure 1) [9,20,21]. Further
indication that the catalytic activity of ATGL reside within the
N-terminal portion of ATGL is based on analysis of TG hydrolase
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with NLSDM. In living cells, these truncated ATGL variants are
not capable of binding to lipid droplets and do not hydrolyze TG
[15,20,21]. Interestingly, these truncated ATGL variants show
increased TG hydrolase activity in vitro [15,20,21].
To date, our understanding of how ATGL activity is regulated
is rather limited. Regulatory mechanisms include phosphorylation,
protein-protein interaction and autoregulation by its own C-
terminal domain [4,16,20,22,23,24]. Very recently, residue
Ser406 was shown to be phosphorylated by AMPK, which results
in the activation of ATGL and enhances lipolysis [25]. A negative
autoregulatory role of the C-terminal half of ATGL was suggested
based on the observation that C-terminally truncated variants of
ATGL showed even increased TG hydrolase activity in vitro as
mentioned above [20,21]. In an interesting study, Duncan et al.
reported interaction between the N-terminal and C-terminal parts
of ATGL, offering a possible explanation for this negative
autoregulatory function [15].
Two proteins have been identified as important regulators for
ATGL’s TG hydrolase activity: comparative gene identification-58
(CGI-58, also known as Abhydrolase domain-containing protein 5,
ABHD5) stimulates the activity of ATGL whereas the protein
G0S2, encoded by the G(0)/G(1) switch gene 2, inhibits ATGL
activity [16,22,26]. Direct protein-protein interactions between
ATGL and full-length CGI-58, as well as N-terminally truncated
variants of CGI-58 have been shown [16,20,22,27]. Our group
could also demonstrate previously, that ATGL stimulation also
depends on the localization of CGI-58 to the LD since mutants of
CGI-58, which were still able to interact with ATGL, failed to
localize on the LD and failed to stimulate ATGL [27]. Other
studies also showed CGI-58 mediated stimulation of ATGL
variants, which were observed in NLSDM patients [20,21,28]. In
2010, G0S2 was identified as specific inhibitor of ATGL [22]. In
the same study, the authors showed direct protein-protein
interaction between G0S2 and an ATGL mutant lacking residues
259–337, which also leads to inhibition of ATGL activity. On the
contrary, ATGL lacking the patatin-region (residue 10–178) did
not interact with G0S2 [22]. G0S2 inhibited ATGL in a dose
depended, non-competitive manner even in the presence of its co-
activator CGI-58 [28].
Thus, data in the literature strongly suggest that stimulation of
ATGL by CGI-58 and inhibition by G0S2 is mediated within the
N-terminal half of ATGL. However, the exact requirements and a
mechanistic explanation for its activation and inhibition are
missing. Therefore, we investigated these important regulatory
processes for ATGL activity. We determined the domain
boundaries of ATGL which are responsible for exerting ATGL’s
TG hydrolyzing activity and its association in a systematic in vitro
approach. Consistent with the existing data, our results show that
C-terminal truncations of ATGL, expressed in E. coli exhibit
increased activity and activation compared to the full length
protein. We identified Leu254 as the domain boundary of ATGL,
which is required for ATGL’s TG hydrolase activity and its
interaction with its co-activator CGI-58. Moreover, TG hydrolase
activity of this minimal region of ATGL could be inhibited by
G0S2. These findings indicate that the 254 N-terminal residues of
ATGL are required and sufficient for TG hydrolysis and
regulatory interactions with its co-activator CGI-58 and its
inhibitor G0S2.
Materials and Methods
Cloning of recombinant proteins
Sequences containing the entire open reading frame of mouse
ATGL (NCBI reference number AY894805), and mouse G0S2
(NCBI reference number NM_008059) were amplified using
FailSafe
TM PCR System (Epicentre Biotechnologies, Madison,
USA) and Phusion Polymerase (New England Biolabs, Ipswich,
USA), respectively. Used primers contained endonuclease cleavage
sites for subsequent cloning procedures. PCR products and
corresponding vectors were digested with the respective restriction
enzymes. Full-length ATGL was cloned into a modified
pET21a(+) (Novagen) vector, which carries a Gb1 sequence at
the N-terminus, for increasing solubility of the fusion protein [29].
Mouse G0S2 was ligated into pCold DNA vector, with an N-
terminal fusion tag, His6-trigger factor (TF) (Takara Bio Inc.,
Otsu, Japan). Shorter C-terminal constructs were produced using
the QuickChangeH Site-Directed Mutagenesis Kit (Agilent
Technologies, USA) introducing a stop codon at the desired
location. Used primers are listed in Table S1. Mouse ATGL 254
(ATGL254-MBP) was cloned also in a modified pMALc2x vector
version E, comprising an uncleavable N-terminal MBP tag
(supplied by Dr. Lars Pedersen, National Institute of Environ-
mental Health Sciences, USA) [30]. All tags were tested as
Figure 1. Domain organization of mouse ATGL and C-terminal truncations used in this study. Graphical representation of the predicted
domain organization: in light yellow: patatin domain (residues 10–178), including the residues forming the proposed catalytic dyad (Ser47 and
Asp166). Dark yellow: the 3-layer (a/b/a) sandwich (residues 10–254); Orange: the putative hydrophobic region. Red arrows indicate the 14 C-terminal
deletions which were used in this study. *as shown in this work.
doi:10.1371/journal.pone.0026349.g001
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any activities. The correct sequence of all inserts was confirmed by
DNA sequencing analysis.
Bacterial expression of recombinant proteins and
preparation of cell extracts
E.coli strains BL21 and BL21(DE3)CodonPlus (Novagen) were
grown in selective LB medium containing 50 mg/ml carbenicillin
or 40 mg/ml kanamycin, respectively. Cultures of mouse
ATGL254-MBP were supplemented with glucose (2 g/l). Expres-
sion of fusion proteins was induced with 0.5 mM IPTG for
3 hours or overnight at 15uC. For the preparation of cell extracts,
cells were disrupted in buffer A (0.25 M sucrose, 1 mM
ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 20 mg/ml
leupeptine, 2 mg/ml antipain, 1 mg/ml pepstatin, 50 mg/ml
lysozyme pH 7.0) by sonication (Bandelin Sonoplus, HD2070,
Berlin, Germany) on ice. Supernatants were collected after
centrifugation at 21,0006g, 4uC for 20 min. Protein concentra-
tions were determined using Bio-Rad protein assay (Bio-rad 785,
Biorad Laboratories, GmbH, Mu ¨nchen, Germany).
Expression of recombinant ATGL constructs in COS-7
cells
SV-40 transformed monkey kidney cells (COS-7, ATCC CRL-
1651) were cultured in DMEM media (Invitrogen, Carlsbad, CA)
with 10% fetal calf serum (Sigma-Aldrich, Taufkirchen, Germany)
under standard conditions (95% humidified atmosphere, 37uC,
5% CO2). For transfections, cells (150.000/dish) were seeded in 6-
well plates (Nunclone
TM, Nalge Nunc, Thermo Scientific,
Rochester, USA) and incubated with 1 mg of pcDNA4/His Max
plasmid coding for mouse ATGL (mATGL) or b-galactosidase
(LacZ) which had been mixed with Metafectene (Biontex GmbH,
Mu ¨nchen, Germany) as described [1]. Cells were harvested 2 days
after transfection.
Purification of mouse CGI-58
N-terminally His6-smt-tagged mouse CGI-58 was expressed as
previously described [27]. Briefly, bacteria from overnight
induction at 37uC were disrupted in 20 mM TrisHCl pH 7.8,
500 mM NaCl, 0.1% Igepal CA-630, 30 mM imidazole, 1 mM
Tris(2-carboxyethyl)phosphine hydrochloride, 1 mM benzami-
dine, 100 mg/ml lysozyme and 0.1 mM phenylmethylsulfonyl
fluoride. Soluble His-tagged fraction was purified by affinity
chromatography using prepacked His-Trap FF 5 ml column (GE
Healthcare, Waukesha, USA). The construct was eluted in 20 mM
TrisHCl pH 7.8, 500 mM NaCl, 40% glycerol, 500 mM
imidazole, 1 mM Tris(2-carboxyethyl)phosphine hydrochloride
and 1 mM benzamidine.
Purification of mouse ATGL254-MBP
After 6 h of expression at 15uC bacteria were lysed in 50 mM
TrisHCl pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM ethylenedi-
aminetetraacetic acid, 1 mM Tris(2-carboxyethyl)phosphine hydro-
chloride, 1 mM benzamidine, 100 mg/ml lysozyme and 0.1 mM
phenylmethylsulfonyl fluoride. For purification of target protein, the
supernatant was incubated with amylose resin (New England Biolabs,
Ipswich, USA) at 4uC, and eluted with 10 mM maltose.
Western Blotting and quantitation
Expressions of ATGL, G0S2 and CGI-58 as fusion–proteins
were confirmed by SDS-PAGE and/or Western blotting analysis
using an anti-His primary antibody and anti-mouse HRP-linked
secondary (GE Healthcare, Waukesha, USA). Chemolumines-
cence was induced using GE Amersham ECL Plus Kit and
detected with a Typhoon 9400 Imager (GE Healthcare). Relative
expression rates were determined using ImageQuant Software 5.2
(GE Healthcare) and the local median method for background
correction.
Assay for TG hydrolase activity
Different amounts of recombinant protein lysates (10–200 mg)
were incubated in a final volume of 100 ml buffer A with 100 mlo f
substrate in a water bath for 60 min at 37uC. Substrate was
prepared by emulsifying 0.33 mM triolein (Sigma, St. Louis, USA),
0.45 mM phosphatidylcholine/phosphatidylinositol (3:1, Sigma,
St. Louis, USA), 0.5% defatted bovine serum albumin (Carl Roth
GmbH, Karlsruhe, Germany) and [9, 10-
3H] triolein
(10,000 cpm/ml; Perkin Elmer Life Sciences, Waltham, USA) as
a radioactive tracer as described [1]. In control experiments,
lysates of cells expressing only the N-terminal tags (Gb1, smt or
Trigger factor -TF) were used. Reactions were terminated by
addition of 3.25 ml of methanol/chloroform/heptane (10:9:7) and
1 ml of 0.1 M potassium carbonate, 0.1 M boric acid pH 10.5
and FAs extracted by vortexing. After centrifugation (8006g,
15 min), radioactivity in 1 ml of the upper phase was determined
by liquid scintillation counting. Activation of ATGL was achieved
by addition of purified CGI-58 (2.5 mg/100 ml reaction). Inhibi-
tion of ATGL in the presence of CGI-58 was tested by adding
bacterial lysate containing G0S2.
Statistical significance was determined by Student’s unpaired t-
test (two tailed). Group differences were considered significant for
p,0.05 (*), p,0.01 (**), and p,0.001 (***).
Protein-protein interaction by ELISA
For the study of protein-protein interaction of truncated
ATGL254 with CGI-58 and G0S2, ELISA plates (MaxiSorp,
Nalge Nunc Int., Rochester, USA) were coated with 1 mg purified
ATGL254-MBP or G0S2 in coating buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl). Then wells were blocked with 5% BSA in
coating buffer. In the next step 1–3 mg of purified His6-smt-tagged
CGI-58 or MBP-tagged ATGL254 were used. As negative
controls purified smt and MBP were verified throughout. After
washing with coating buffer containing 0.05% Tween 20, mouse
anti-his antibody (GE Healthcare), diluted 1:500 in coating buffer
containing 0.5% BSA was added for detection of His-tagged
proteins. After three washes, horseradish peroxidase-conjugated
anti-mouse antibody (GE Healthcare) was added at a dilution of
1:1000. Alternatively, for the detection of ATGL254-MBP protein
the plates were incubated with Anti-MBP-HRP antibody (New
England Biolabs, Ipswich, USA). After three washes, tetramethyl-
benzidine and H2O2 were added and the reaction stopped by
addition of HCl. Absorbance was determined at 450 nm using
620 nm as reference wavelength.
3D Model of mouse ATGL
The Yasara software suite was used for homology modeling of
the minimum active domain of ATGL. 3D coordinates of patatin
17 (Pat17, PDB code 1OXW, Ala23-Y316) and the catalytic
domain of cPLA2 (PDB code 1CJY, residues Val187-Val641) were
used as templates [31]. The sequence identities of ATGL254 were
only 12% when aligned with Pat17 and 10% with cPLA2. The Z-
scores of the model calculated by Yasara were 20.189 for dihedral
angles, 23.037 and 22.891 for 1D and 3D packing, respectively.
The quality and the geometry of the model was also assessed using
MolProbity [32]. The all-atom clashscore (giving the number of
serious steric overlaps per 1000 atoms) was 0.51. 92.9% and
98.8% of the residues were found in the favored and allowed
The Minimal Domain of ATGL
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ATGL ranging from residue 4–189 or 4–320 is also predicted in
the Protein Model Portal [33]. The highest scoring models
calculated using the Phyre server also used Pat17 and cPLA2 as
templates [34]. These modeled regions (10–178 using Pat17, or 3–
101 and 3–61 using cPLA2 as template) share the same overall fold
as our model of ATGL254 in the identical regions. It should also
be noted that both prediction servers also picked up short stretches
with similarities to malonyl CoA-acyl carrier protein transacylase.
The alignment of the model, Pat17 and the catalytic domain of
cPLA2 was performed using lsqman [35].
Results
Activation and inhibition of ATGL can be studied in a
simplified model system of lipolysis
In order to gain more insight into the basic mechanism and
structural requirements of ATGL function, its stimulation by CGI-
58 and inhibition by G0S2, we expanded a simplified experimen-
tal setup which was used before to mimic the first step of lipolysis
[27]. Thereby, only TG hydrolysis per se is reconstituted with
proteins expressed in E.coli and an artificial TG substrate. In vitro
assays with mouse ATGL (mATGL) expressed in bacterial cultures
harbors the advantages of eliminating possible unidentified factors
responsible for reported cell-type dependence and the influence of
eukaryotic proteins (e.g. LD associated proteins) from the complex
equation of lipolysis.
Previously we had shown that the activity of mATGL can also
be stimulated by mouse CGI-58 (mCGI-58) expressed in E. coli
[27]. We first wanted to verify that bacterially expressed mouse
G0S2 (mG0S2) is functional at inhibiting mATGL expressed in
COS-7 cells after activation by CGI-58. Indeed, inhibition of
mATGL expressed in COS-7 and also in E.coli was observed upon
addition of mG0S2 from E.coli lysates in a similar manner
(Figure 2A and B). This indicates, that the underlying protein-
protein interaction is independent from post-translational modi-
fications and can be studied at the level of heterologously
expressed proteins.
In all our assays, mG0S2 was added as N-terminal His6-
Trigger-factor (TF) fusion protein. This fused protein does not
inhibit ATGL activity by itself and the effect of G0S2 was
compared with ATGL activity/stimulation in presence of this
fusion partner. Expression of the various proteins was confirmed
by Western blotting analysis (for ATGL constructs) and SDS-
PAGE (for the other recombinant proteins) (Figure 2C).
ATGL’s TG hydrolyzing activity is abrogated upon
deletion of the C-terminal residues beyond Leu254
Next, we determined the minimal length of ATGL which is
catalytically active in TG hydrolysis. Previous reports indicate that
Figure 2. TG hydrolase activity of full length ATGL is inhibited by G0S2. A. Mouse ATGL (mATGL) contained in COS-7 cell lysates were
subjected to in vitro TG hydrolase activity assay in the presence of CGI-58 (*) and without or with addition of bacterially expressed mouse G0S2
(mG0S2), using radiolabeled triolein as artificial substrate. B. E. coli expressed mATGL was assayed in in vitro TG hydrolase activity assay without or
with mG0S2 as above. Gb1, the fusion tag of mATGL, does not exhibit TG hydrolase activity. Representative assays (performed in triplicates) of three
independent experiments are shown. Data are presented as mean+SD. *** indicate statistical significant differences as determined by unpaired
Student’s t-test (two-tailed), p.0.001. As control, the corresponding fusion tag (Trigger factor –TF for mG0S2) was added to the reaction. C. Western
blots confirming expression of mATGL in COS-7 cells and in E.coli. SDS-PAGE showing purified CGI-58 (,54 kDa) and bacterial lysates of TF-mG0S2
(64 kDa), and TF alone (54 kDa). As a control, lysates of non induced cells were used.
doi:10.1371/journal.pone.0026349.g002
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portions of the protein [20,21]. To date, the shortest ATGL
construct reported to be still active in hydrolyzing TG was an N-
terminal region of the protein truncated at residue 289 [20].
In order to determine the minimal domain for ATGL activity,
we generated 14 different C-terminally truncated ATGL variants,
heterologously expressed them in E coli, and subjected lysates to
hydrolase activity assay (Figure 1 and Table S1). We chose ATGL
truncations based on the predicted overall domain organization,
secondary structure, and sequence conservation within mamma-
lian species. Sequence conservation between human and mouse
ATGL showed a clear distinction between the highly conserved N-
terminal half (residues 1–266, 92% sequence identity) and the less
conserved C-terminal half (residues 267–486, 81% sequence
identity).
Results of TG hydrolase assays clearly demonstrated that
truncated proteins of mATGL up to Leu254 (termed ATGL254
throughout this paper) retained the ability to hydrolyze TG
(Figure 3A). In contrast, mATGL variants with truncations closer
to the N-terminus, at residues 253, 252, 245 and 235, lost their TG
hydrolyzing activity. Thus, we can conclude that ATGL254
represents the shortest fragment of ATGL which retains TG
hydrolase activity (Figure 3A). Next, we correlated specific
activities of truncated variants to full-length ATGL. The rational
for this approach is that enzymatic activities measured in protein
lysates obviously depend on the amount of the protein in the
soluble fraction. In addition, this procedure allowed us to place
these data in context with previous reports, which showed higher
activities of C-terminally truncated ATGL variants [20]. Western
Blot analysis confirmed the presence of soluble ATGL variants in
the lysates. Differences in the expression and solubility levels were
evident (Figure 3B). To account for these differences in
expression/solubility levels, results of the Western Blot was
analyzed densitometrically and used for calculating relative
activity rates. These relative activities, as depicted in Figure 3C,
clearly demonstrate that shorter fragments of ATGL have higher
intrinsic in vitro TG hydrolyzing activity when compared to full-
length ATGL. The activity of C-terminal ATGL truncations was
ablated when shorter fragments than ATGL254 were tested
(Figure 3C), in line with ATGL254 as the minimal fragment
required for ATGL activity.
CGI-58 stimulates C-terminal truncations of ATGL
including ATGL254
In the next experiments we asked whether shortened versions of
ATGL can also be stimulated by addition of CGI-58. Therefore,
we performed TG hydrolase experiments using full-length ATGL
and C-terminally truncated variants in the presence of mCGI-58
and related measured activities to activated full-length ATGL
levels. Interestingly, all active fragments of ATGL were stimulated
by CGI-58 (Figure 4). Importantly, ATGL254 was also stimulated
by CGI-58, suggesting that this fragment of ATGL is still capable
of interacting with CGI-58. Consequently, C-terminal residues of
ATGL beyond Leu254 are not essential for activation by CGI-58.
Shorter constructs, such as ATGL253 and ATGL252, retained
virtually no detectable TG hydrolase activity and were not
stimulated to a significant extent by CGI-58 (,77% and 90%,
respectively, less than full length ATGL; Figure 4). As expected, all
shorter constructs tested (ATGL245 and ATGL235) were inactive
and could not be activated by CGI-58 (data not shown). These
data clearly demonstrate that ATGL254 is the shortest fragment of
mATGL that retains the ability to be activated efficiently by CGI-
58.
Shortest active fragment of mouse ATGL can also be
inhibited by G0S2
Next we asked whether ATGL254, the minimal active fragment
of ATGL, can also be inhibited by G0S2. As shown in Figure 5,
CGI-58 activated ATGL254 can be inhibited by addition of
bacterial lysate of G0S2. This also suggests that the protein
surfaces for interaction of ATGL with G0S2 reside within the first
254 residues of the protein, similar to the results observed for
protein interaction with CGI-58.
ATGL254 physically interacts with CGI-58 and G0S2
To further substantiate our conclusions that ATGL254 is
sufficient for regulation by CGI-58 and G0S2, the implied
physical interaction between the involved proteins was also
determined by ELISA experiments. For this purpose, plates were
coated with purified ATGL254 or mG0S2. Then, wells were
incubated with purified His6-smt-tagged CGI-58 or maltose
binding protein (MBP)-tagged ATGL254. As expected, protein-
protein interactions between the ATGL254 and its co-activator
CGI-58, as well as its inhibitor G0S2 were detected (Figure 6A
and B). These data further support the conclusion that
ATGL254 harbors all residues required for catalytic activity as
well as interaction with ATGL’s regulatory proteins, CGI-58 and
G0S2.
The 3D model of ATGL indicates that residues beyond
amino acid Leu178 are involved in completing the
patatin-related domain
After establishing the minimal requirements for retaining
ATGL’s enzymatic activity, we wanted to gain more insight
into the structural background enabling the catalytic activity
and its protein-protein interactions. Currently, no experimental
3D structure is available for ATGL. Therefore we performed
homology modeling of ATGL ranging until residue Leu254.
Pat17 and cPLA2, the two patatin family members with known
3D structures, were used as templates. Due to the overall low
sequence identity with the templates, the resulting models do
n o tp r o v i d ea t o m i cd e t a i l s .T h e r e f o r ei tc a n n o tb eu s e df o r
detailed interpretation of the structure, however should be
viewed as giving a glimpse of the overall structure of the protein
and its domain boundaries. Insights into the potential domain
architecture of the N-terminal half of ATGL are given by the
model (Figure 7). The template Pat17 is a 386 residue protein.
Its crystal structure revealed a single-domain protein, harboring
ac e n t r a lb-sheet with two a-helices on the concave side and 7
a-helices on the convex side. Although the patatin fold shares
similarities with the canonical a/b hydrolase fold, it also
harbors features that are clearly distinct from the a/b hydrolase
fold, e.g. a six-stranded sheet as the core, in which five parallel
sheets are followed by one anti-parallel strand, and the
hydrolytic activity is carried out by a catalytic dyad [14]. In
the 3D model of ATGL254, the catalytic dyad residues Ser47
and Asp166 along with a potential oxyanion hole forming
residues Gly14-Phe17 are in an overall spatial arrangement
which allows enzymatic activity. Residues Asn9-Leu178 in
mATGL (blue in Figure 7A and C), which correspond to
residues Thr30–Leu227 in Pat17, contribute to 4 of the 6
strands in the central b-sheet. The helical packing on the
convex side of the central sheet of the ATGL model allows the
formation of a compact arrangement of secondary structure
elements. However, residues within this range are only involved
in forming one partial a-helix at the concave side of the protein
(Figure 7A and C, compare also with Figure 3 in [4]).
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sufficient to build a stable and functional protein domain and
that residues beyond Lys179 (cyan in Figure 7A and C) play an
integral part in forming the active protein domain. Interest-
ingly, residues Lys180 to Leu254 further complement the
central parallel b-sheet and form helices on the concave side of
the sheet in our model (colored cyan in Figure 7A). These
residues are probably essential for a stable fold of ATGL and
play a crucial role in creating the core of this protein domain.
In summary, our 3D modeling data are in agreement with our
biochemical observations, showing that residues within the N-
terminal part of ATGL until Leu254 are essential for forming a
stable, active protein domain.
Discussion
ATGL is the rate-limiting enzyme of lipolysis and its enzymatic
activity is enhanced by CGI-58 and inhibited by G0S2 [1,16,22].
Mechanistic explanations for ATGL’s activation and inhibition are
rather scarce. Mutagenesis studies confirm the importance of the
proposed catalytic dyad residues Ser47 and Asp166 [15,16,17]. C-
terminal truncations with premature stop-codons and frame shifts
(Q289X, W367X, FS270, FS282) that retain TG-hydrolyzing
capacity have also been reported [15,20,21]. Some of these
truncations show an apparent increased in vitro catalytic activity
and suggest a regulatory role for the C-terminal region of ATGL
[15,20,21].
Figure 3. The N-terminal region of ATGL up to residue 255 is necessary for enzymatic activity. A. C-terminally truncated ATGL variants
were expressed in E.coli, lysates prepared, and TG hydrolase activity determined in vitro using radiolabeled triolein as substrate. The determined
activity was normalized to bacterial lysate protein contents. The experiment was performed in triplicates. A representative result of three
independent experiments is shown. B. Expression was assessed by Western blotting and ATGL in the soluble fraction of the bacterial lysates was
quantified by densitometric analysis. C. TG hydrolase activities obtained in A were normalized to expression levels of ATGL variants as assessed in B.
Data are presented as mean+SD.
doi:10.1371/journal.pone.0026349.g003
The Minimal Domain of ATGL
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26349In the present study we determined the minimal domain
requirements of ATGL for enzymatic activity and the basis for its
interaction with CGI-58 and G0S2. In agreement with previous
reports, we show that C-terminal truncations beyond residue 280
are functional in hydrolyzing TG. Our systematic approach to
determine the minimal domain requirements for activity
(Figure 3A) demonstrated that the loss of activity is very abrupt
when comparing the activity of the truncations at residues Leu255,
Leu254, and Gly253. C-terminal deletions up to Leu254 retain
TG hydrolase activity, implying that the structural basis for
enzymatic activity is also preserved. Possible explanations for the
loss of activity of larger truncations are incorrect folding of the
minimal domain and/or failure of substrate recognition.
The TG hydrolyzing activity of the tested ATGL constructs did
not diminish gradually, on the contrary, higher levels of activities
were observed for all C-terminally truncated fragments compared
to full-length protein (Figures 3 and 4). Especially high activities in
the presence and absence of CGI-58 (,3.5 fold increase compared
to full length ATGL) were observed for the last two active C-
terminally truncated ATGL variants, ATGL255 and ATGL254.
Such high activities could result from the previously reported
inhibitory effect of C-terminal regions of the protein [20].
Interestingly, the shortest active ATGL fragment ATGL254 also
retained the ability to be inhibited by G0S2 (Figure 5), indicating
that the interaction surface of ATGL with its protein inhibitor is
also located within the N-terminal half of the protein. This was
further confirmed by protein-protein interaction studies demon-
strating protein-protein interaction between ATGL254 and
ATGL’s regulatory proteins CGI-58 and G0S2 (Figure 6A and
B). Nevertheless, additional modulation of protein-protein inter-
action of ATGL with CGI-58 and/or G0S2 by C-terminal
residues of ATGL cannot be ruled out at this point.
The finding that mATGL variant ATGL254 is active in
hydrolyzing TG and interacts with CGI-58 and G0S2, prompted
us to generate a 3D structure model (Figure 7). The model
provides first structural insights into the structure of the
functionally active minimum domain of ATGL and an overall
structural arrangement of the active site. It shows that the 3D
Figure 4. CGI-58 stimulates C-terminal truncation variants of ATGL including ATGL254. TG hydrolase assay with different C-terminal
truncations of ATGL, in the presence (*) of purified CGI-58, was performed as described in Figure 2. TG hydrolase activities were normalized to that of
full length ATGL (=100%). Data are presented as mean+SD. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0026349.g004
Figure 5. Minimal active fragment of ATGL can be inhibited by G0S2. A. ATGL254 was expressed in E. coli, lysates prepared, and TG
hydrolase activity assay performed in the presence of purified CGI-58 (*), without and with addition of mG0S2 as described in Figure 2. Data are
presented as mean+SD and representative for three independent experiments, each performed in triplicates. *** indicate statistical significant
differences as determined by unpaired Student’s t-test (two-tailed), p.0.001. B. Western Blotting analysis of ATGL254 expression and SDS-PAGE gel
confirming expression of mG0S2 in bacterial lysate.
doi:10.1371/journal.pone.0026349.g005
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(dark blue)) build a mostly parallel sheet with a-helices flanking
one side of the protein (Figure 7A and C) [14]. However, the 3D
structures of Pat17 and cPLA2 harbor additional b-strands in their
central sheet and a-helices also pack at the other side of the
protein. Our model of ATGL indicates that residues up to Leu254
might form the apparently missing components of the core
structure by adding two helices on the concave face of the strand
and being just sufficient to form a six-stranded central b-sheet
(Figure 7). Therefore, we propose that the patatin-related region of
ATGL stretches beyond residue Leu178 and also includes amino
acids until residue Leu254.
It is also interesting to note, that high sequence identity of
ATGL (PNPLA2) with other members of the PNPLA family
(PNPLA1, PNPLA3, PNPLA5) continues further than the usually
proposed patatin-domain (residue 10–178 in PNPLA2, highlighted
in red bold in Figure 8). Mouse PNPLA2 and PNPLA1 share 66%
and 67% similarity within residues 10–178 and 5–254, respectively
(numbers refer to PNPLA2). Mouse PNPLA2, PNPLA3, and
PNPLA5 shares 63% and 60% similarity within residues 10–178
and 5–254, respectively. Interestingly, sequence alignments display
larger gaps and a drop in sequence identity after Leu254 (indicated
in pink in Figure 8). This could indicate a boundary from a
commonly shared domain and the beginning of a separate domain
or a Pro-rich linker region. Only few studies on enzymatic
activities for the human orthologs of these enzymes are published
and report predominantly TG-hydrolyzing activity in addition to
low transacylase and phospholipase A2 activity for PNPLA2; TG-
hydrolase, transacylase and modest phospholipase A2 activity for
PNPLA3. The biochemical functions of PNPLA1 and PNPLA5
are still elusive. These similar activities could be exerted by the
well-aligned regions, whereas the remaining C-terminal residues
could modulate enzymatic function and substrate specificities of
the full-length proteins.
The experimentally determined requirements for the minimum
active domain of mATGL are also supported by the following
observations: i) Secondary structure prediction: It is predicted that
a and b elements are ranging until residue Ala264 before the start
of a long loop region; ii) Sequence conservation across species:
Analysis of the amino acid sequences of ATGL orthologs from
Figure 6. ELISA experiment demonstrating that ATGL254 interacts with CGI-58 and G0S2. A. ELISA plates were coated with purified
ATGL254-MBP and then incubated with purified His-tagged CGI-58. Purified smt (the fusion tag for CGI-58) was used as a negative control. Detection
was performed by anti-his-antibody, HRP-labeled secondary antibody and tetramethyl-benzidine as substrate. B. ELISA plates were coated with
purified mG0S2 and then incubated with purified ATGL254-MBP. Purified MBP was used as negative control. Detection was performed using an anti-
MBP (HRP conjugated) antibody and otherwise as in A. Data are presented as mean+SD and representative for 2 independent experiments
(performed in triplicates). C. SDS-PAGE confirming the expression and purification of respective fusion proteins.
doi:10.1371/journal.pone.0026349.g006
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bmm) shows strong sequence conservation up to residue Leu254.
Mouse and rat ATGL show 99% sequence identity within the first
278 amino acids, before the start of an apparent linker region in
mouse ATGL (Gln288-Asp295), which seems to be missing in the
sequence for rat ATGL. In humans, a highly conserved 253
residue long patatin domain containing protein PNPLA4 (also
known as gene sequence-2 (GS2)) has also been described, hinting
at a domain boundary in this region (this protein is not present in
the mouse PNPLA family); and iii) Expression levels of ATGL
variants: shorter variants of ATGL than ATGL254 were either
misfolded, unsoluble, or degraded rapidly as deduced from the low
concentration of these variants in the soluble fractions of bacterial
lysates.
ATGL fragments shorter than ATGL254 failed to exert
hydrolytic activity despite the presence of the proposed catalytic
residues Ser47 and Asp166. According to our model this could be
due to the fact that the protein is not folded properly, e.g. the last
b-strand of the central sheet cannot be formed anymore, thus
yielding a an inactive protein.
Several mutations in the N-terminal half of human ATGL have
been observed in patients suffering from NLSDM [9,10,36]. These
can also be discussed in view of the homology model of ATGL: A
duplication event on the sequence level at the position coding for
residue 160 leads to the loss of the catalytic residue Asp166 and a
premature stop codon at amino acid 178, which obviously explains
the lack of function. Deletion events on the sequence level at
positions coding for residues Asn180 or Pro231 lead to the loss of
Figure 7. Model of mouse ATGL254. A. Homology-modeled structure of mouse ATGL ranging from residue Met1-Leu254 in cartoon
representation. Residues Trp8-Leu178 are colored in light blue. Ser47 and Asp166, which form the catalytic dyad, are colored by atom; Gly14-Phe17,
which are thought to be involved in forming the oxyanion hole are in red. N- and C-termini are indicated. B. Structural alignment of Pat17 (PDB code
1OXW) and cPLA2 (PDB code 1CJY) with the 3D model of ATGL254. Residues at the catalytic site (oxyanion hole, GXSXG motif, catalytic Asp) are
highlighted in red. a-helices and b-strands are indicated in green and orange, respectively. Red numbers indicate extra amino acids in the structure of
Pat17 and cPLA2. C. Left panel: model of ATGL254; middle panel: overlay of the 3D model of ATGL254 with Pat17 (colored grey and yellow); right
panel: structure of Pat17. Val319-Lys383 of Pat17 (yellow) suggest a possible further structural organization of approximately 60 additional residues in
mATGL.
doi:10.1371/journal.pone.0026349.g007
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strand and two b-strands of the central sheet. In full agreement
with our in vitro data, these truncated proteins are not functional
for TG hydrolase activity of ATGL. A single missense mutation
(Pro195Leu) is reported to result in an enzymatically completely
inactive protein [20]. Pro195 resides in a surface exposed loop and
thus could be involved in protein-protein interaction surfaces or
influence protein dynamics.
Recently, Duncan et al. also tested point mutations of N-
terminal glycines (Gly14Ala, Gly16Ala, Gly19Ala) and hydro-
phobic residues (Phe17Ala, Leu18Ala, Val20Ala). According to
our model, this region is involved in forming the oxyanion hole in
the active site of ATGL (Figure 7A). The formation of this loop
and correct positioning of the backbone amides as H-bond
donors could also be facilitated by the NH backbone atoms of the
rather small amino acid Ala, used for those point mutations.
Thus, the retention of the catalytic activity of some of those
constructs could be explained. cPLA2 and Pat17 both have an
Arg residue (Gly-Gly-X-Arg) after the oxyanion hole, which is
thought to stabilize the phosphate moiety of a phospholipid
substrate with its side chain guanidinium group. Our 3D model
of ATGL harbors hydrophobic amino acids in a partly surface
exposed turn and an a helix following the oxyanion hole forming
residues. These hydrophobic amino acids might contribute to the
specific selectivity of ATGL and/or the correct fold of the
protein.
Figure 8. Amino acid sequence alignment of PNPLA family members. The amino acid sequence alignment of mouse PNPLA family members
PNPLA1, -2, -3, and -5 shows high sequence conservation at the N-terminal halves of the proteins. Residues at the proposed catalytic sites (oxyanion
hole, GXSXG motif, catalytic Asp) are highlighted in yellow. The patatin domain (Ile10-Leu178 for ATGL/PNPLA2) is emphasized in bold red letters.
High identity can be also observed in the patatin-related region, up to Leu254 (bold blue).
doi:10.1371/journal.pone.0026349.g008
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additional residues (Val319-Lys383 and Phe640-Tyr719), which
are not included in the sequence alignment used for the model
ATGL254. These residues form mainly a-helical elements, which
complete the 3D structures (Val319-Lys383 colored yellow for
Pat17 in Figure 7C). Despite low sequence identity in this region
between Pat17 and mATGL, secondary prediction of residues C-
terminal of ATGL254 also predicts a-helices and loop regions. It
will be interesting to see from an experimentally determined
structure of mATGL whether these additional residues indeed
adopt a similar conformation.
In summary our results provide insights into the domain
boundaries of the active fragment of ATGL to be at residue
Leu254, and restrict the essential interaction region with ATGL’s
regulators CGI-58 and G0S2. The calculated 3D homology model
further supports the notion that the patatin-related region of
ATGL does not stop at residue Leu178 but ranges at least until
residue Leu254.
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